CD8A and neoplasm: This cascade triggered robust type I interferon production, enhanced DC-mediated antigen presentation, and activated tumor-specific CD8+ T cells, effectively overcoming immunosuppression in melanoma and achieving synergistic radio-immunotherapeutic effects [135].